News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Sanofi (France) Halts Clinical Trial of Heart Drug Multaq
July 7, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sanofi is halting a clinical trial aimed at getting another indication approved for its key heart drug Multaq after it saw increased cardiovascular problems among patients taking the drug.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Europe
Sanofi
MORE ON THIS TOPIC
Approvals
Merck dives into cholesterol with first FDA approval for oral PCSK9 inhibitor
July 16, 2026
·
2 min read
·
Gabrielle Masson
Insights
The future of pain relief: Exploring opioid alternatives
July 16, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Lung cancer
Kelun’s Merck-partnered ADC notches late-stage NSCLC win alongside Keytruda
July 15, 2026
·
2 min read
·
Michael Gibney
Antibody-drug conjugate
Pfizer scraps Seagen-developed ADC for solid tumors
July 15, 2026
·
1 min read
·
Gabrielle Masson
